跳至主要内容
临床试验/JPRN-UMIN000020903
JPRN-UMIN000020903招募中2 期

A Phase 2 Trial of Multimodal Treatment based on VDC-IE with Interval Compressed Schedule by using G-CSF for Patients with Non-metastatic Ewing Sarcoma Family Tumor - Interval Compressed VDC-IE for Non-metastatic ESFT (JESS14)

Japan Ewing Sarcoma Study Group0 个研究点目标入组 66 人开始时间: 2016年2月5日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
66

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 50years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Patients with synchronous or metachronous concomitant malignancies. 2)Patients who are pregnant or breast feeding mother. 3)Patients with mental disorder who is considered inappropriate for study participation. 4)Patients with heart disease which required any therapy. 5)Patients with active infection which required any therapy. 6)Patients with any other inappropriate condition for study participation judged by physician. 7)HBs antigen positive. HBs antigen negative but HBc antibody or HBs antibody positive.( exclude HBs antibody positive due to HBV vaccination) 8)Patients who had continuous steroid therapy.

研究者

发起方
Japan Ewing Sarcoma Study Group

相似试验